Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 3449

BillFederalSenateIn Committee
Registration of Certain Foreign Establishments Act
About This Bill
Committee
Latest Action · January 10, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Congress
117th (2021–2023)
Introduced
January 10, 2022
Cosponsors (1)
0D 1R
View PDF ↗

Summary

Highlight any text to annotate
Registration of Certain Foreign Establishments Act This bill expands statutory provisions that require foreign manufacturers of drugs or medical devices for the U.S. market to register with the Food and Drug Administration. Specifically, if an establishment outside of the United States manufactures (or otherwise processes or prepares) a drug or medical device to be imported (or offered for import) into the United States, the establishment must comply with the registration requirements even if the drug or medical device in question undergoes further manufacturing at another non-U.S. establishment prior to importation into the United States.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.